Halozyme Therapeutics shares owned by Dixon Hubard Feinour & Brown
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Dixon Hubard Feinour & Brown
from 13F filings
Historical chart of Dixon Hubard Feinour & Brown investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Dixon Hubard Feinour & Brown consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Dixon Hubard Feinour & Brown
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2022-06-30 | $890k | 20k | 44.02 |
2022-03-31 | $806k | 20k | 39.87 |
2021-12-31 | $805k | 20k | 40.21 |
2021-09-30 | $772k | 19k | 40.70 |
2021-06-30 | $634k | 14k | 45.39 |
2021-03-31 | $367k | 14k | 26.27 |
2020-12-31 | $367k | 14k | 26.27 |
2020-09-30 | $367k | 14k | 26.27 |
2020-06-30 | $380k | 14k | 27.21 |
2020-03-31 | $251k | 14k | 17.97 |
2019-12-31 | $248k | 14k | 17.75 |
2019-09-30 | $217k | 14k | 15.54 |
2019-06-30 | $271k | 16k | 17.19 |
2019-03-31 | $269k | 17k | 16.11 |
2018-12-31 | $244k | 17k | 14.61 |
2018-09-30 | $303k | 17k | 18.14 |
2018-06-30 | $282k | 17k | 16.88 |
2018-03-31 | $338k | 17k | 19.61 |
2017-12-31 | $349k | 17k | 20.25 |
2017-09-30 | $312k | 18k | 17.39 |
2017-06-30 | $230k | 18k | 12.82 |
2017-03-31 | $233k | 18k | 12.98 |
2016-12-31 | $177k | 18k | 9.86 |
2016-09-30 | $217k | 18k | 12.09 |
More positions owned by Dixon Hubard Feinour & Brown
View all positions for Dixon Hubard Feinour & Brown